2014 Q3 Form 10-K Financial Statement

#000114420414058476 Filed on September 30, 2014

View on sec.gov

Income Statement

Concept 2014 Q3 2014 Q2 2014
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $1.780M $1.540M $4.470M
YoY Change 157.97% 52.48% -26.24%
% of Gross Profit
Research & Development $112.6K $30.00K $34.32K
YoY Change 882.17%
% of Gross Profit
Depreciation & Amortization $27.40K $10.00K $7.759K
YoY Change
% of Gross Profit
Operating Expenses $2.235M $2.230M $5.176M
YoY Change 218.89% 120.79% -15.24%
Operating Profit -$2.235M -$5.176M
YoY Change 218.89% -15.24%
Interest Expense $500.00 $220.0K $4.230M
YoY Change -99.7% -1200.0% 643.61%
% of Operating Profit
Other Income/Expense, Net $20.43K -$4.554M
YoY Change -117.22% 633.9%
Pretax Income -$2.210M -$2.010M -$9.730M
YoY Change 169.51% 95.15% 44.58%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$2.215M -$2.010M -$9.730M
YoY Change 170.24% 95.15% 44.64%
Net Earnings / Revenue
Basic Earnings Per Share -$1.04
Diluted Earnings Per Share -$6.139M -$5.743M -$1.04
COMMON SHARES
Basic Shares Outstanding 18.09M shares 17.72M shares 9.385M shares
Diluted Shares Outstanding 9.385M shares

Balance Sheet

Concept 2014 Q3 2014 Q2 2014
SHORT-TERM ASSETS
Cash & Short-Term Investments $4.300M $5.930M $5.930M
YoY Change
Cash & Equivalents $4.300M $5.930M $5.930M
Short-Term Investments
Other Short-Term Assets $95.88K $83.43K $80.00K
YoY Change 90.92% -12.62% -80.95%
Inventory $301.9K $289.6K $290.0K
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $4.696M $6.308M $6.310M
YoY Change 715.17% 673.41% 669.51%
LONG-TERM ASSETS
Property, Plant & Equipment $812.2K $337.9K $340.0K
YoY Change 190.06% 22.56% 21.43%
Goodwill
YoY Change
Intangibles $9.161K
YoY Change
Long-Term Investments
YoY Change
Other Assets $750.0K $750.0K $750.0K
YoY Change
Total Long-Term Assets $1.571M $1.097M $1.090M
YoY Change 446.38% 280.38% 289.29%
TOTAL ASSETS
Total Short-Term Assets $4.696M $6.308M $6.310M
Total Long-Term Assets $1.571M $1.097M $1.090M
Total Assets $6.267M $7.405M $7.400M
YoY Change 625.68% 570.73% 572.73%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $700.0K $460.3K $860.0K
YoY Change 71.2% 144.4% -14.0%
Accrued Expenses $10.00K $10.00K $10.00K
YoY Change -97.87% -97.37% -97.37%
Deferred Revenue
YoY Change
Short-Term Debt $60.00K $60.00K $60.00K
YoY Change -98.39% -98.39% -98.39%
Long-Term Debt Due $80.00K
YoY Change
Total Short-Term Liabilities $892.9K $964.0K $960.0K
YoY Change -84.28% -81.69% -81.78%
LONG-TERM LIABILITIES
Long-Term Debt $100.0K $0.00 $0.00
YoY Change
Other Long-Term Liabilities $253.1K $33.88K $30.00K
YoY Change
Total Long-Term Liabilities $354.8K $33.88K $30.00K
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $892.9K $964.0K $960.0K
Total Long-Term Liabilities $354.8K $33.88K $30.00K
Total Liabilities $1.248M $997.9K $1.000M
YoY Change -78.03% -81.05% -81.02%
SHAREHOLDERS EQUITY
Retained Earnings -$17.75M
YoY Change
Common Stock $18.22K $18.09K
YoY Change -54.46% 171.37%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $5.019M $6.407M $6.410M
YoY Change
Total Liabilities & Shareholders Equity $6.267M $7.405M $7.400M
YoY Change 625.68% 570.73% 572.73%

Cashflow Statement

Concept 2014 Q3 2014 Q2 2014
OPERATING ACTIVITIES
Net Income -$2.215M -$2.010M -$9.730M
YoY Change 170.24% 95.15% 44.64%
Depreciation, Depletion And Amortization $27.40K $10.00K $7.759K
YoY Change
Cash From Operating Activities -$1.470M -$2.100M -$3.170M
YoY Change -40143.58% 813.04% 94.72%
INVESTING ACTIVITIES
Capital Expenditures -$170.0K -$70.00K -$70.00K
YoY Change -86.27%
Acquisitions
YoY Change
Other Investing Activities $0.00 -$750.0K -$760.0K
YoY Change -208.57%
Cash From Investing Activities -$170.0K -$820.0K -$830.0K
YoY Change 4821.83% -548.37%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 3.210M 9.930M
YoY Change -2106.25% 600.53%
NET CHANGE
Cash From Operating Activities -1.470M -2.100M -3.170M
Cash From Investing Activities -170.0K -820.0K -830.0K
Cash From Financing Activities 0.000 3.210M 9.930M
Net Change In Cash -1.640M 290.0K 5.930M
YoY Change -755860.37% -174.36% -23491.58%
FREE CASH FLOW
Cash From Operating Activities -$1.470M -$2.100M -$3.170M
Capital Expenditures -$170.0K -$70.00K -$70.00K
Free Cash Flow -$1.300M -$2.030M -$3.100M
YoY Change 782.61% 177.29%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2013Q2 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
3732500 USD
CY2014 us-gaap Use Of Estimates
UseOfEstimates
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify"><strong><i>Accounting Estimates</i></strong> - The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts in the financial statements and the accompanying notes. Such estimates and assumptions impact, among others, the following: estimated useful lives and potential impairment of intangible assets, the fair value of share-based payments&#160;and warrants, estimates of the probability and potential magnitude of contingent liabilities and the valuation allowance for deferred tax assets due to continuing and expected future operating losses. Actual results could differ from those estimates.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2013Q2 us-gaap Other Assets Current
OtherAssetsCurrent
95469 USD
CY2013Q2 us-gaap Assets Noncurrent
AssetsNoncurrent
288422 USD
CY2014Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
337932 USD
CY2014Q2 us-gaap Other Assets Current
OtherAssetsCurrent
83425 USD
CY2014Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2013Q2 us-gaap Common Stock Value
CommonStockValue
6667 USD
CY2014Q2 us-gaap Common Stock Value
CommonStockValue
18092 USD
CY2013Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
3847591 USD
CY2014Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
24135563 USD
CY2013Q2 us-gaap Stockholders Equity
StockholdersEquity
-4162212 USD
CY2014Q2 us-gaap Stockholders Equity
StockholdersEquity
6406731 USD
CY2013Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1103971 USD
CY2014Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
7404652 USD
CY2014Q2 us-gaap Cash
Cash
5934534 USD
CY2013Q2 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
157761 USD
CY2013Q2 us-gaap Liabilities Current
LiabilitiesCurrent
5266183 USD
CY2013Q2 us-gaap Cash
Cash
527 USD
CY2013Q2 us-gaap Notes Receivable Related Parties Current
NotesReceivableRelatedPartiesCurrent
163829 USD
CY2014Q2 us-gaap Notes Receivable Related Parties Current
NotesReceivableRelatedPartiesCurrent
0 USD
CY2013Q2 us-gaap Interest Receivable Current
InterestReceivableCurrent
3341 USD
CY2014Q2 us-gaap Interest Receivable Current
InterestReceivableCurrent
0 USD
CY2013Q2 us-gaap Inventory Net
InventoryNet
223000 USD
CY2014Q2 us-gaap Inventory Net
InventoryNet
289600 USD
CY2013Q2 us-gaap Related Party Transaction Due From To Related Party Current
RelatedPartyTransactionDueFromToRelatedPartyCurrent
183346 USD
CY2014Q2 us-gaap Related Party Transaction Due From To Related Party Current
RelatedPartyTransactionDueFromToRelatedPartyCurrent
0 USD
CY2013Q2 us-gaap Deferred Finance Costs Current Net
DeferredFinanceCostsCurrentNet
146037 USD
CY2014Q2 us-gaap Deferred Finance Costs Current Net
DeferredFinanceCostsCurrentNet
0 USD
CY2013Q2 us-gaap Assets Current
AssetsCurrent
815549 USD
CY2014Q2 us-gaap Assets Current
AssetsCurrent
6307559 USD
CY2013Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
275717 USD
CY2013Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
12705 USD
CY2014Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
9161 USD
CY2014Q2 us-gaap Assets Noncurrent
AssetsNoncurrent
1097093 USD
CY2013Q2 us-gaap Assets
Assets
1103971 USD
CY2014Q2 us-gaap Assets
Assets
7404652 USD
CY2013Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
188346 USD
CY2014Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
460311 USD
CY2013Q2 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
807001 USD
CY2014Q2 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
397055 USD
CY2014Q2 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
60000 USD
CY2013Q2 us-gaap Interest Payable Current
InterestPayableCurrent
380575 USD
CY2014Q2 us-gaap Interest Payable Current
InterestPayableCurrent
11079 USD
CY2014Q2 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
35595 USD
CY2014Q2 us-gaap Liabilities Current
LiabilitiesCurrent
964040 USD
CY2013Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2014Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2013Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2013Q2 us-gaap Development Stage Enterprise Deficit Accumulated During Development Stage
DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage
8016470 USD
CY2014Q2 us-gaap Development Stage Enterprise Deficit Accumulated During Development Stage
DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage
17746924 USD
CY2014 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
34317 USD
CY2014Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2014Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2014Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2014Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2014Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2014Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
18091792 shares
CY2014Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
18091792 shares
CY2014 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
Effective May 1, 2014, the Company effected a 6 to 1 reverse split of the Companys common stock, in which for every six (6) shares of common stock combined into one (1) share of common stock.
CY2013Q2 us-gaap Financial Instruments Owned At Fair Value
FinancialInstrumentsOwnedAtFairValue
-157761 USD
CY2014 antb Fair Value Of Financial Instruments Earnings
FairValueOfFinancialInstrumentsEarnings
336489 USD
CY2014 antb Fair Value Of Financial Instruments Warrant Reclassified To Equity
FairValueOfFinancialInstrumentsWarrantReclassifiedToEquity
1407739 USD
CY2014Q2 us-gaap Financial Instruments Owned At Fair Value
FinancialInstrumentsOwnedAtFairValue
-35595 USD
CY2013Q1 antb Business Acquisition Purchase Price Allocation Current Assets Inventory1
BusinessAcquisitionPurchasePriceAllocationCurrentAssetsInventory1
223000 USD
CY2013Q1 antb Business Acquisition Purchase Price Allocation Fixed Assets
BusinessAcquisitionPurchasePriceAllocationFixedAssets
264000 USD
CY2013Q1 antb Business Acquisition Purchase Price Allocation Intangible Assets Other Than Goodwill1
BusinessAcquisitionPurchasePriceAllocationIntangibleAssetsOtherThanGoodwill1
13000 USD
CY2013Q1 antb Business Acquisitions Cost Of Acquired Entity Purchase Price
BusinessAcquisitionsCostOfAcquiredEntityPurchasePrice
500000 USD
CY2013Q1 us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
400000 USD
CY2013Q1 antb Business Acquisition Purchases Price Allocation Assets Acquired
BusinessAcquisitionPurchasesPriceAllocationAssetsAcquired
100000 USD
CY2013Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2014Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2013Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2013Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2013Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2013Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2013Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2013Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
6666667 shares
CY2013Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
6666667 shares
CY2011Q3 antb Line Of Credit Issued To Related Party
LineOfCreditIssuedToRelatedParty
1000000 USD
CY2014 antb Fair Value Of Warrants
FairValueOfWarrants
35595 USD
CY2014 us-gaap Line Of Credit Facility Interest Rate Description
LineOfCreditFacilityInterestRateDescription
The line of credit bears interest equal to the lower of 10%, or the Wall Street Journal Prime Rate (3.25% at June 30, 2013) plus 5%.
CY2013Q2 us-gaap Line Of Credit Facility Interest Rate At Period End
LineOfCreditFacilityInterestRateAtPeriodEnd
0.0825 pure
CY2012Q4 us-gaap Line Of Credit Facility Interest Rate During Period
LineOfCreditFacilityInterestRateDuringPeriod
0.05 pure
CY2014 us-gaap Line Of Credit Facility Description
LineOfCreditFacilityDescription
The line of credit was for a period of one year and matured on August 31, 2012.
CY2013 antb Consulting Expenses
ConsultingExpenses
598995 USD
CY2014 antb Consulting Expenses
ConsultingExpenses
321205 USD
CY2013Q2 antb Related Party Expenses
RelatedPartyExpenses
807001 USD
CY2014Q2 antb Related Party Expenses
RelatedPartyExpenses
397055 USD
CY2013Q2 us-gaap Due From Related Parties
DueFromRelatedParties
183346 USD
CY2013Q2 us-gaap Line Of Credit
LineOfCredit
163829 USD
CY2014Q2 us-gaap Line Of Credit
LineOfCredit
0 USD
CY2014Q2 us-gaap Due From Related Parties
DueFromRelatedParties
0 USD
CY2013Q2 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
3732500 USD
CY2014Q2 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
60000 USD
CY2014Q2 antb Third Party Capital Investment
ThirdPartyCapitalInvestment
2500000 USD
CY2011Q2 antb Percentage Of Common Share Price Of Financing
PercentageOfCommonSharePriceOfFinancing
0.65 pure
CY2014 antb Percentage Of Common Share Price Of Financing
PercentageOfCommonSharePriceOfFinancing
0.65 pure
CY2011Q2 antb Maximum Convertible Notes Payable Issuance
MaximumConvertibleNotesPayableIssuance
2000000 USD
CY2012Q3 antb Maximum Convertible Notes Payable Issuance
MaximumConvertibleNotesPayableIssuance
2000000 USD
CY2012Q4 antb Maximum Convertible Notes Payable Issuance
MaximumConvertibleNotesPayableIssuance
1000000 USD
CY2011Q2 antb Qualified Offering Common Stock
QualifiedOfferingCommonStock
5000000 USD
CY2011Q2 antb Maximum Conversion Pre Money Valuation
MaximumConversionPreMoneyValuation
20000000 USD
CY2011Q2 antb Percentage Of Exercise Per Share On Price Per Common Share
PercentageOfExercisePerShareOnPricePerCommonShare
1.35 pure
CY2012Q3 antb Description Of Convertible Notes
DescriptionOfConvertibleNotes
On the maturity date of the convertible notes, or the closing of a Sale of the Company, whichever occurs first, the lenders are permitted an elective conversion option to convert the outstanding principal and interest on the convertible notes at the lower of 65% of the price per share of common stock in the Qualified Financing or 65% of the common stock price using a pre-money valuation of the Company of $20 million.
CY2012Q4 antb Description Of Convertible Notes
DescriptionOfConvertibleNotes
On the date of a Qualified Financing, the lenders are permitted an elective conversion option to convert the outstanding principal and interest at the lower of 50% of the price per share of common stock in the Qualified Financing or $4.50 per share.
CY2012Q3 antb Percentage Of Price Per Common Share On Warrant To Purchase Two Shares Of Common Stock
PercentageOfPricePerCommonShareOnWarrantToPurchaseTwoSharesOfCommonStock
1.35 pure
CY2012Q4 antb Percentage Of Price Per Common Share On Warrant To Purchase One Share Of Common Stock
PercentageOfPricePerCommonShareOnWarrantToPurchaseOneShareOfCommonStock
1.5 pure
CY2012Q3 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.08 pure
CY2012Q4 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.08 pure
CY2013Q4 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.08 pure
CY2013Q4 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
2703000 USD
CY2014 antb Additional Warrants Issued
AdditionalWarrantsIssued
562352 shares
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1508334 shares
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
2835000 shares
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1508334 shares
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4343334 shares
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1387871 shares
CY2012Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0
CY2013 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
4.50
CY2014 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
3.14
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.50
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.61
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
4.33
CY2012 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P0Y
CY2013 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y7M6D
CY2014 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y7M6D
CY2014 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P4Y
CY2013Q1 antb Share Based Compensation Arrangement By Share Based Payment Award Options Shares Purchased Vested Immediately
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsSharesPurchasedVestedImmediately
819445 shares
CY2013 us-gaap Share Based Compensation
ShareBasedCompensation
3687502 USD
CY2013Q1 antb Share Based Compensation Arrangement By Share Based Payment Award Options Shares Purchased Vested Monthly
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsSharesPurchasedVestedMonthly
541667 shares
CY2013Q1 antb Share Based Compensation Arrangement By Share Based Payment Award Options Shares Purchased Vested Monthly Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsSharesPurchasedVestedMonthlyTerm
P0Y
CY2013 us-gaap Interest Paid
InterestPaid
0 USD
CY2014 us-gaap Share Based Compensation
ShareBasedCompensation
1081792 USD
CY2014Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
7756739 USD
CY2014Q1 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
233334 shares
CY2014Q2 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
41424 shares
CY2014Q2 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
290861 shares
CY2014Q2 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
290861 shares
CY2012Q2 antb Proceeds From Issuance Of Stock Option To Purchase Of Common Stock
ProceedsFromIssuanceOfStockOptionToPurchaseOfCommonStock
3500000 shares
CY2013 antb Consulting Fees
ConsultingFees
647925 USD
CY2014 antb Consulting Fees
ConsultingFees
579817 USD
CY2013 antb Payroll Expenses
PayrollExpenses
4485064 USD
CY2014 antb Payroll Expenses
PayrollExpenses
2260598 USD
CY2013 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3494 USD
CY2013 us-gaap General Insurance Expense
GeneralInsuranceExpense
101276 USD
CY2014 us-gaap General Insurance Expense
GeneralInsuranceExpense
154722 USD
CY2013 us-gaap Professional Fees
ProfessionalFees
620162 USD
CY2014 us-gaap Professional Fees
ProfessionalFees
724385 USD
CY2013 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
73256 USD
CY2014 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
134952 USD
CY2013 antb Travel Expenses
TravelExpenses
90048 USD
CY2014 antb Travel Expenses
TravelExpenses
106421 USD
CY2013 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
28660 USD
CY2014 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
475042 USD
CY2013 us-gaap Operating Expenses
OperatingExpenses
6106881 USD
CY2014 us-gaap Operating Expenses
OperatingExpenses
5176033 USD
CY2013 us-gaap Operating Income Loss
OperatingIncomeLoss
-6106881 USD
CY2014 us-gaap Operating Income Loss
OperatingIncomeLoss
-5176033 USD
CY2013 us-gaap Investment Income Interest
InvestmentIncomeInterest
106044 USD
CY2014 us-gaap Investment Income Interest
InvestmentIncomeInterest
12180 USD
CY2013 us-gaap Interest Expense
InterestExpense
568859 USD
CY2014 us-gaap Interest Expense
InterestExpense
4230112 USD
CY2013 us-gaap Other General Expense
OtherGeneralExpense
157761 USD
CY2014 us-gaap Other General Expense
OtherGeneralExpense
336489 USD
CY2013 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-620576 USD
CY2014 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-4554421 USD
CY2013 us-gaap Net Income Loss
NetIncomeLoss
-6727457 USD
CY2014 us-gaap Net Income Loss
NetIncomeLoss
-9730454 USD
CY2012Q2 us-gaap Stockholders Equity
StockholdersEquity
-1288913 USD
CY2013 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3687502 USD
CY2014 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1081792 USD
CY2014 us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
2922938 USD
CY2013 antb Class Of Warrant Or Right Expense
ClassOfWarrantOrRightExpense
191126 USD
CY2014 antb Fair Value Of Warrants For Financing And Conversion
FairValueOfWarrantsForFinancingAndConversion
6476606 USD
CY2013 us-gaap Stockholders Equity Note Spinoff Transaction
StockholdersEquityNoteSpinoffTransaction
-24470 USD
CY2014 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
3483408 USD
CY2014 us-gaap Stock Issued During Period Value Conversion Of Units
StockIssuedDuringPeriodValueConversionOfUnits
4964879 USD
CY2014 antb Stock Issued During Period Value Related Party
StockIssuedDuringPeriodValueRelatedParty
275000 USD
CY2013 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
19312 USD
CY2014 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
3356000 USD
CY2013 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
279096 USD
CY2014 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
416337 USD
CY2013 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
295 USD
CY2014 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3544 USD
CY2013 antb Warrant Expense
WarrantExpense
0 USD
CY2014 antb Warrant Expense
WarrantExpense
126427 USD
CY2014 us-gaap Increase Decrease In Interest And Dividends Receivable
IncreaseDecreaseInInterestAndDividendsReceivable
10211 USD
CY2013 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
0 USD
CY2014 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
341780 USD
CY2013 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-6706 USD
CY2014 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-12044 USD
CY2013 antb Proceeds From Issuance Of Notes Receivable Related Party
ProceedsFromIssuanceOfNotesReceivableRelatedParty
-305603 USD
CY2014 antb Proceeds From Issuance Of Notes Receivable Related Party
ProceedsFromIssuanceOfNotesReceivableRelatedParty
0 USD
CY2013 antb Payment To Acquire Notes Receivable Related Parties
PaymentToAcquireNotesReceivableRelatedParties
-974228 USD
CY2014 antb Payment To Acquire Notes Receivable Related Parties
PaymentToAcquireNotesReceivableRelatedParties
0 USD
CY2013 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
185114 USD
CY2014 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-830185 USD
CY2014 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
353091 USD
CY2013 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-1627965 USD
CY2014 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-3167357 USD
CY2013 us-gaap Payments For Purchase Of Other Assets1
PaymentsForPurchaseOfOtherAssets1
11717 USD
CY2014 us-gaap Payments For Purchase Of Other Assets1
PaymentsForPurchaseOfOtherAssets1
69974 USD
CY2013 us-gaap Payments To Acquire Assets Investing Activities
PaymentsToAcquireAssetsInvestingActivities
500000 USD
CY2014 us-gaap Payments To Acquire Assets Investing Activities
PaymentsToAcquireAssetsInvestingActivities
0 USD
CY2013 us-gaap Increase Decrease In Interest And Dividends Receivable
IncreaseDecreaseInInterestAndDividendsReceivable
-28206 USD
CY2013 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
157500 USD
CY2014 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
270300 USD
CY2013 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
1575000 USD
CY2014 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
2703000 USD
CY2013 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
0 USD
CY2014 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
67500 USD
CY2013 antb Proceeds From Issuance Of Notes Payable Related Party
ProceedsFromIssuanceOfNotesPayableRelatedParty
0 USD
CY2014 antb Proceeds From Issuance Of Notes Payable Related Party
ProceedsFromIssuanceOfNotesPayableRelatedParty
234700 USD
CY2013 us-gaap Increase Decrease In Due From Related Parties
IncreaseDecreaseInDueFromRelatedParties
206609 USD
CY2014 us-gaap Increase Decrease In Due From Related Parties
IncreaseDecreaseInDueFromRelatedParties
-18947 USD
CY2013 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
80117 USD
CY2014 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
271965 USD
CY2013 us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
804861 USD
CY2014 us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
-134946 USD
CY2013 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
270451 USD
CY2013 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
0 USD
CY2014 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
8931434 USD
CY2013 us-gaap Payment Of Financing And Stock Issuance Costs
PaymentOfFinancingAndStockIssuanceCosts
0 USD
CY2014 us-gaap Payment Of Financing And Stock Issuance Costs
PaymentOfFinancingAndStockIssuanceCosts
1365085 USD
CY2013 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
1417500 USD
CY2014 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
9931549 USD
CY2013 us-gaap Cash Period Increase Decrease
CashPeriodIncreaseDecrease
-25351 USD
CY2014 us-gaap Cash Period Increase Decrease
CashPeriodIncreaseDecrease
5934007 USD
CY2012Q2 us-gaap Cash
Cash
25878 USD
CY2013 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
CY2014 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
CY2014 us-gaap Interest Paid
InterestPaid
15726 USD
CY2013 us-gaap Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1
NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1
1207 USD
CY2014 us-gaap Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1
NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1
0 USD
CY2013 antb Assumption Of Related Party In Reverse Merger
AssumptionOfRelatedPartyInReverseMerger
23263 USD
CY2014 antb Assumption Of Related Party In Reverse Merger
AssumptionOfRelatedPartyInReverseMerger
0 USD
CY2013 antb Conversion Of Convertible Notes Payable To Common Stock
ConversionOfConvertibleNotesPayableToCommonStock
0 USD
CY2014 antb Conversion Of Convertible Notes Payable To Common Stock
ConversionOfConvertibleNotesPayableToCommonStock
6308000 USD
CY2013 antb Conversion Of Interest Payable To Common Stock
ConversionOfInterestPayableToCommonStock
0 USD
CY2014 antb Conversion Of Interest Payable To Common Stock
ConversionOfInterestPayableToCommonStock
722587 USD
CY2013 antb Conversion Of Accounts Payable And Accrued Expense Related Party
ConversionOfAccountsPayableAndAccruedExpenseRelatedParty
0 USD
CY2014 antb Conversion Of Accounts Payable And Accrued Expense Related Party
ConversionOfAccountsPayableAndAccruedExpenseRelatedParty
275000 USD
CY2013 us-gaap Debt Instrument Convertible Beneficial Conversion Feature
DebtInstrumentConvertibleBeneficialConversionFeature
0 USD
CY2014 us-gaap Debt Instrument Convertible Beneficial Conversion Feature
DebtInstrumentConvertibleBeneficialConversionFeature
2922938 USD
CY2013 antb Warrant Value Recorded As Debt Discount
WarrantValueRecordedAsDebtDiscount
0 USD
CY2014 antb Warrant Value Recorded As Debt Discount
WarrantValueRecordedAsDebtDiscount
433062 USD
CY2013 us-gaap Noncash Or Part Noncash Acquisition Inventory Acquired1
NoncashOrPartNoncashAcquisitionInventoryAcquired1
223000 USD
CY2014 us-gaap Noncash Or Part Noncash Acquisition Inventory Acquired1
NoncashOrPartNoncashAcquisitionInventoryAcquired1
0 USD
CY2013 us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
264000 USD
CY2014 us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
0 USD
CY2013 antb Fair Value Of Financial Instruments Warrant Reclassified To Equity
FairValueOfFinancialInstrumentsWarrantReclassifiedToEquity
0 USD
CY2013 us-gaap Noncash Or Part Noncash Acquisition Intangible Assets Acquired1
NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1
13000 USD
CY2014 us-gaap Noncash Or Part Noncash Acquisition Intangible Assets Acquired1
NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1
0 USD
CY2013 antb Cash Paid For Asset Acquisition
CashPaidForAssetAcquisition
500000 USD
CY2014 antb Cash Paid For Asset Acquisition
CashPaidForAssetAcquisition
0 USD
CY2014 us-gaap Nature Of Operations
NatureOfOperations
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify"><b><u>Note 1 Nature of Operations</u></b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify"><b>&#160;</b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify">These financial statements represent the consolidated financial statements of AntriaBio, Inc. (&#8220;AntriaBio&#8221;), formerly known as Fits My Style, Inc., and its wholly owned operating subsidiary, AntriaBio Delaware, Inc. (&#8220;Antria Delaware&#8221;). AntriaBio and Antria Delaware are collectively referred to herein as the &#8220;Company&#8221;.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify">On January 31, 2013, Antria Delaware merged with AntriaBio, a public company pursuant to a share exchange agreement in which the existing shareholders of Antria Delaware exchanged all of their issued and outstanding shares of common stock of Antria Delaware for <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 5,880,667</font> shares of common stock of AntriaBio (the &#8220;Reverse Merger&#8221;). After the consummation of the Reverse Merger, stockholders of Antria Delaware own <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 88.2</font>% of AntriaBio&#8217;s outstanding common stock.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify">As a result of the Reverse Merger, Antria Delaware became a wholly owned subsidiary of AntriaBio. For accounting purposes, the Reverse Merger was treated as a reverse acquisition with Antria Delaware as the acquirer and AntriaBio as the acquired party. As a result, the business and financial information included in this Annual Report on Form 10-K is the business and financial information of Antria Delaware. The accumulated deficit of AntriaBio has been included in additional paid-in-capital. Pro-forma information has not been presented as the financial information of AntriaBio was insignificant.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify"> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">Effective May 1, 2014, the Company effected a 6 to 1 reverse split of the Company&#8217;s common stock, in which for every six (6) shares of common stock combined into one (1) share of common stock.</font> All share and per share amounts have been retroactively restated to reflect the forward split.</div> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2014 dei Document Type
DocumentType
10-K
CY2014 dei Amendment Flag
AmendmentFlag
false
CY2014 dei Document Period End Date
DocumentPeriodEndDate
2014-06-30
CY2014 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2014
CY2014 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2014 dei Entity Registrant Name
EntityRegistrantName
AntriaBio, Inc.
CY2014 dei Entity Central Index Key
EntityCentralIndexKey
0001509261
CY2014 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
CY2014 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2014 dei Entity Voluntary Filers
EntityVoluntaryFilers
Yes
CY2014 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2014 dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
CY2013Q4 dei Entity Public Float
EntityPublicFloat
2768480 USD
CY2014 dei Trading Symbol
TradingSymbol
ANTB
CY2014Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
18091792 shares
CY2013Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
0 USD
CY2014Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
33881 USD
CY2013Q2 us-gaap Liabilities
Liabilities
5266183 USD
CY2014Q2 us-gaap Liabilities
Liabilities
997921 USD
CY2013 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
0 USD
CY2013 antb Meals And Entertainment Expenses
MealsAndEntertainmentExpenses
17670 USD
CY2014 antb Meals And Entertainment Expenses
MealsAndEntertainmentExpenses
32562 USD
CY2014 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> <strong><i>Reclassifications</i></strong> <i>&#150;</i> Certain amounts reported in prior years in the Consolidated Financial Statements have been reclassified to conform to the current year&#8217;s presentation.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2013 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.08
CY2014 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.04
CY2013 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.08
CY2014 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.04
CY2013 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6204568 shares
CY2014 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9384662 shares
CY2013 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6204568 shares
CY2014 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9384662 shares
CY2013 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2014 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2013 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0 USD
CY2014 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0 USD
CY2013Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
2468821 USD
CY2014Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
4555200 USD
CY2013Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 USD
CY2014Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 USD
CY2013 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
2293815 USD
CY2014 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
3308354 USD
CY2014 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
0 USD
CY2013 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0 USD
CY2014 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0 USD
CY2013 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
2052267 USD
CY2014 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
2006831 USD
CY2013 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
184451 USD
CY2014 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
79548 USD
CY2013 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
2236718 USD
CY2014 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
2086379 USD
CY2013 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0 USD
CY2014 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0 USD
CY2013Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
562335 USD
CY2014Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
2267379 USD
CY2013Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Other
DeferredTaxAssetsTaxDeferredExpenseOther
580219 USD
CY2014Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Other
DeferredTaxAssetsTaxDeferredExpenseOther
457495 USD
CY2013Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
1265350 USD
CY2014Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
1683247 USD
CY2013Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Other
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther
60943 USD
CY2014Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Other
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther
129986 USD
CY2013Q2 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
-26 USD
CY2014Q2 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
17093 USD
CY2013Q2 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
2468821 USD
CY2014Q2 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
4555200 USD
CY2013 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
184451 USD
CY2014 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
79549 USD
CY2013Q2 us-gaap Accumulated Amortization Deferred Finance Costs
AccumulatedAmortizationDeferredFinanceCosts
362088 USD
CY2013 antb Permenant Differences
PermenantDifferences
241548 USD
CY2014 antb Permenant Differences
PermenantDifferences
1301524 USD
CY2014 us-gaap Income Tax Examination Likelihood Of Unfavorable Settlement
IncomeTaxExaminationLikelihoodOfUnfavorableSettlement
An uncertain income tax position will not be recognized if it has less than a 50% likelihood of being sustained.
CY2014Q2 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
5869000 USD
CY2014 antb Operating Loss Carryforwards Expiration Year
OperatingLossCarryforwardsExpirationYear
2031
CY2014 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.34 pure
CY2014Q2 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
262183 USD
CY2014Q2 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
359468 USD
CY2014Q2 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
370252 USD
CY2014Q2 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
381360 USD
CY2014Q2 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
392855 USD
CY2014Q2 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
335747 USD
CY2014Q2 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
2101865 USD
CY2014Q2 antb Term Of Lease
TermOfLease
P72M
CY2014Q2 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
28939 USD
CY2014Q2 antb Payments Of Monthly Lease Adjusted Annually Percentage
PaymentsOfMonthlyLeaseAdjustedAnnuallyPercentage
0.03 pure
CY2014Q2 antb Adjusted Triple Net Expense Of Lease Payments
AdjustedTripleNetExpenseOfLeasePayments
36427 USD
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.94 pure
CY2014 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P7Y
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2013Q2 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
0 USD
CY2014Q2 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
750000 USD
CY2013Q2 antb Deferred Lease Liability Non Current
DeferredLeaseLiabilityNonCurrent
0 USD
CY2014Q2 antb Deferred Lease Liability Non Current
DeferredLeaseLiabilityNonCurrent
33881 USD
CY2014Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
1181 USD
CY2014Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
1181 USD
CY2014Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
1181 USD
CY2014Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
1181 USD
CY2013 us-gaap Depreciation And Amortization
DepreciationAndAmortization
295 USD
CY2014 us-gaap Depreciation And Amortization
DepreciationAndAmortization
11303 USD
CY2014Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
1181 USD
CY2014 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
0 USD
CY2014 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
404587 USD
CY2013 us-gaap Depreciation
Depreciation
0 USD
CY2014 us-gaap Depreciation
Depreciation
7759 USD
CY2013 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
0 USD
CY2014 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
404587 USD
CY2013 antb Deferred Lease Liability
DeferredLeaseLiability
0 USD
CY2014 antb Deferred Lease Liability
DeferredLeaseLiability
33881 USD
CY2013 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
0 USD
CY2014 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
66600 USD
CY2013 us-gaap Payments For Deposits
PaymentsForDeposits
0 USD
CY2014 us-gaap Payments For Deposits
PaymentsForDeposits
750000 USD
CY2013 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
0 USD
CY2014 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
234700 USD
CY2013Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
275717 USD
CY2014Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
345691 USD
CY2013Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
0 USD
CY2014Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
7759 USD
CY2014Q2 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
690187 USD
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
41570 shares
CY2014 antb Advertising Expenses For Common Stock
AdvertisingExpensesForCommonStock
404587 USD
CY2014Q1 antb Services Agreement Expenses
ServicesAgreementExpenses
500000 USD
CY2014Q1 us-gaap Area Of Land
AreaOfLand
27000 sqft
CY2013 us-gaap Line Of Credit Facility Increase Accrued Interest
LineOfCreditFacilityIncreaseAccruedInterest
3341 USD
CY2014 us-gaap Line Of Credit Facility Increase Accrued Interest
LineOfCreditFacilityIncreaseAccruedInterest
0 USD
CY2013Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
138888 shares
CY2014Q2 us-gaap Security Deposit
SecurityDeposit
750000 USD
CY2013 antb Investor Relations
InvestorRelations
39031 USD
CY2014 antb Investor Relations
InvestorRelations
661914 USD
CY2013 antb Warrant Value Recorded As Issuance Costs
WarrantValueRecordedAsIssuanceCosts
0 USD
CY2014 antb Warrant Value Recorded As Issuance Costs
WarrantValueRecordedAsIssuanceCosts
898719 USD
CY2014 antb Warrants Recorded As Derivative Liability
WarrantsRecordedAsDerivativeLiability
-949084 USD
CY2014 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
690187 USD

Files In Submission

Name View Source Status
0001144204-14-058476-index-headers.html Edgar Link pending
0001144204-14-058476-index.html Edgar Link pending
0001144204-14-058476.txt Edgar Link pending
0001144204-14-058476-xbrl.zip Edgar Link pending
antb-20140630.xml Edgar Link completed
antb-20140630.xsd Edgar Link pending
antb-20140630_cal.xml Edgar Link unprocessable
antb-20140630_def.xml Edgar Link unprocessable
antb-20140630_lab.xml Edgar Link unprocessable
antb-20140630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
v387691_10k.htm Edgar Link pending
v387691_ex21-1.htm Edgar Link pending
v387691_ex31-1.htm Edgar Link pending
v387691_ex31-2.htm Edgar Link pending
v387691_ex32-1.htm Edgar Link pending
v387691_ex32-2.htm Edgar Link pending